Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease

NCT01087385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2015-04-15

No results posted yet for this study

Summary

Study hypothesis: elevated Troponin T is a marker of increased mortality in patients with peripheral arterial occlusive disease (PAOD).

Conditions

  • Peripheral Arterial Occlusive Disease

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    collaborator OTHER
  • University Heart Center Freiburg - Bad Krozingen

    lead OTHER

Principal Investigators

  • Birgit Linnemann, M.D. · Heart Center Bad Krozingen, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087385 on ClinicalTrials.gov